Active Ankylosing Spondylitis Clinical Trials

9 clinical trials for Active Ankylosing Spondylitis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Korean Post-marketing Surveillance for Xeljanz XR — RECRUITING
• Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. — RECRUITING · PHASE3
• A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS — RECRUITING · PHASE2
• Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS — COMPLETED · PHASE2
• Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. — COMPLETED · PHASE2
• Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis — COMPLETED · PHASE2
• A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FILGOTINIB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS WHO ARE NAIVE TO BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG THERAPY, AMD 1 — COMPLETED · PHASE3
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease — COMPLETED · PHASE3
• "A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO-CONTROLLED 16-WEEK STUDY FOLLOWED BY LONG-TERM EVALUATION OF EFFICACY AND SAFETY OF IXEKIZUMAB (LY2349821) IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS." — NOT_YET_RECRUITING

Refine this search